Pursant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parenteral Drugs has informed that the company has attached Unaudited Financial Results (on both Standalone and Consolidated basis) for the quarter ended 31st December, 2019.
The above information is a part of company’s filings submitted to BSE.